Page last updated: 2024-09-04

naproxen and n-methylaspartate

naproxen has been researched along with n-methylaspartate in 2 studies

Compound Research Comparison

Studies
(naproxen)
Trials
(naproxen)
Recent Studies (post-2010)
(naproxen)
Studies
(n-methylaspartate)
Trials
(n-methylaspartate)
Recent Studies (post-2010) (n-methylaspartate)
4,5511,0571,42910,408591,902

Protein Interaction Comparison

ProteinTaxonomynaproxen (IC50)n-methylaspartate (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)5.175

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hewett, JA; Hewett, SJ; Silakova, JM2

Other Studies

2 other study(ies) available for naproxen and n-methylaspartate

ArticleYear
Naproxen reduces excitotoxic neurodegeneration in vivo with an extended therapeutic window.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 309, Issue:3

    Topics: Animals; Dizocilpine Maleate; Male; Mice; N-Methylaspartate; Naproxen; Nerve Degeneration; Neuroprotective Agents; Time Factors

2004
Oral treatment with rofecoxib reduces hippocampal excitotoxic neurodegeneration.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:3

    Topics: Animals; Blotting, Western; Brain Edema; Cell Death; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Excitatory Amino Acid Agonists; Hippocampus; Lactones; Male; Mice; Microinjections; N-Methylaspartate; Naproxen; Nerve Degeneration; Neurons; Neuroprotective Agents; Sulfones

2006